Table 3: Postoperative data.

Group (I) (n = 34) Group (II) (n = 43) P value Significance
Mechanical ventilation time (hrs) 13.20 ± 2.31 6.1 ± 2.58 < 0.05 Significant
Inotropic support (hrs) 14.9 ± 2.6 11.8 ± 3.5 > 0.05 NS
ICU stay (hrs) 59.51 ± 1.12 46.34 ± 3.45 < 0.05 Significant
Total blood loss (ml) 332.5 ± 415.1 347.07 ± 457.2 > 0.05 NS
Glucose level (before ICU discharge) (mg/dl) 190.5 ± 10.6 191.5 ± 35.1 > 0.05 NS
Glucose level (before hospital discharge) (mg/dl) 139.2 ± 27.7 147.3 ± 18.5 > 0.05 NS
Peak serum creatinine (mg/dl) 1.10 ± 0.15 0.70 ± 0.22 > 0.05 Significant
Perioperative MI 2 (5.88%) 1 (2.32%) > 0.05 NS
Low cardiac output syndrome 3 (8.82%) 1 (2.32%) < 0.05 Significant
Operative mortality 1 (2.94%) 1 (2.32%) > 0.05 NS
Stroke/TIAs 4 (11.76%) 1 (2.32%) < 0.05 Significant
Atrial Fibrillation 3 (8.82%) 3 (6.98%) > 0.05 NS
Ventricular arrhythmias 4 (11.76%) 5 (11.62%) > 0.05 NS
Haemorrhagic complications 1 (2.94%) 1 (2.32%) > 0.05 NS
Deep wound infection 2 (5.88%) 3 (6.98%) > 0.05 NS
Superficial wound infection 2 (5.88%) 2 (4.65%) > 0.05 NS
Respiratory complications 5 (14.70%) 4 (9.30%) > 0.05 NS
Acute renal failure 3 (8.82%) 1 (2.32%) < 0.05 Significant
Postoperative IABP insertion 3 (8.82%) 1 (2.32%) < 0.05 Significant
Total hospital stay (days) 9.87 ± 3.56 6.17 ± 1.52 < 0.05 Significant
Overall hospital complications 12 (35.29%) 13 (30.23%) > 0.05 NS
Mortality in follow-up period 1 (2.94%) 1 (2.32%) > 0.05 NS
Overall one-year survival 32 (94.11%) 41 (95.34%) > 0.05 NS

(Data were expressed as mean ± standard deviation (SD) or number (%), NS = Not Significant).